|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||23.32 - 23.32|
|52 Week Range||21.50 - 29.25|
|Beta (5Y Monthly)||0.61|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.78 (3.36%)|
|Ex-Dividend Date||Sep. 24, 2021|
|1y Target Est||N/A|
NEW YORK, NY / ACCESSWIRE / April 21, 2021 / Castellum AB (OTC PINK:CWQXY) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 21, 2021 at 9:00 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.
Oakville, Ontario--(Newsfile Corp. - March 2, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) ("Cardiol" or the "Company"), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, announced today that it has submitted an application to uplist the Company's common shares on The Nasdaq Capital Market® (the "Nasdaq") and that it has received proceeds of over $10 million from the exercise of warrants and ...